Metraipolis › archive › dc_2e08bebb7fea

Gemcitabine as maintenance treatment of diffuse pleural mesothelioma: randomized phase II study — Europe PMC PMID:41888696

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41888696
DOI
10.1186/s12885-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-03T20:57:32.295Z
SHA-256 of the archived text
686a5b984f771a8d52887af16eeeedf7e1668bf32f133182148b26e57d06a8f6
Stable URL of this page
https://metraipolis.com/documento/dc_2e08bebb7fea

How to cite

Gemcitabine as maintenance treatment of diffuse pleural mesothelioma: randomized phase II study — Europe PMC PMID:41888696 — Europe PMC (en), https://europepmc.org/article/MED/41888696 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2e08bebb7fea (Metraipolis archive dc_2e08bebb7fea, sha256 686a5b984f771a8d52887af16eeeedf7e1668bf32f133182148b26e57d06a8f6)
BibTeX
@misc{dc2e08bebb7fea,
  title = {Gemcitabine as maintenance treatment of diffuse pleural mesothelioma: randomized phase II study — Europe PMC PMID:41888696},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41888696},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2e08bebb7fea; sha256 686a5b984f771a8d52887af16eeeedf7e1668bf32f133182148b26e57d06a8f6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41888696. Agents can read the archived copy with the MCP tool read_document.